663 related articles for article (PubMed ID: 27456261)
1. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
[TBL] [Abstract][Full Text] [Related]
2. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
3. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
[TBL] [Abstract][Full Text] [Related]
6. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
7. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
9. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
10. Impact of diabetes on the predictive value of heart failure biomarkers.
Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
Rørth R; Jhund PS; Kristensen SL; Desai AS; Køber L; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Eur J Heart Fail; 2019 Jan; 21(1):40-49. PubMed ID: 30537261
[TBL] [Abstract][Full Text] [Related]
12. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.
Aimo A; Januzzi JL; Vergaro G; Ripoli A; Latini R; Masson S; Magnoli M; Anand IS; Cohn JN; Tavazzi L; Tognoni G; Gravning J; Ueland T; Nymo SH; Rocca HB; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Wilson Tang WH; Grodin JL; Passino C; Emdin M
Int J Cardiol; 2019 Feb; 277():166-172. PubMed ID: 30416028
[TBL] [Abstract][Full Text] [Related]
14. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
15. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure.
Lok DJ; Klip IT; Lok SI; Bruggink-André de la Porte PW; Badings E; van Wijngaarden J; Voors AA; de Boer RA; van Veldhuisen DJ; van der Meer P
Am J Cardiol; 2013 Sep; 112(6):831-7. PubMed ID: 23820571
[TBL] [Abstract][Full Text] [Related]
16. Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus.
Resl M; Vila G; Heinzl M; Luger A; Neuhold S; Prager R; Wurm R; Hülsmann M; Clodi M
J Diabetes Complications; 2021 Sep; 35(9):107990. PubMed ID: 34294516
[TBL] [Abstract][Full Text] [Related]
17. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
Bansal N; Zelnick L; Shlipak MG; Anderson A; Christenson R; Deo R; deFilippi C; Feldman H; Lash J; He J; Kusek J; Ky B; Seliger S; Soliman EZ; Go AS;
Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
[TBL] [Abstract][Full Text] [Related]
18. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients.
Brynildsen J; Petäjä L; Pettilä V; Nygård S; Vaara ST; Linko R; Okkonen M; Hagve TA; Soininen L; Suojaranta-Ylinen R; Lyngbakken MN; Omland T; Røsjø H
Clin Biochem; 2018 Mar; 53():65-71. PubMed ID: 29371002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]